Opinion: Justice Delayed, Health Denied

African justice systems must change to help curb HIV and tuberculosis transmission in prisons.

Written byJoseph Amon
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Convicted prisoners outside a cell at Mumbwa Prison. Inmates at prisons with associated farm facilities, like Mumbwa, often work in the fields 7 days a week, where they are frequently beaten and have no toilet facilities or water. © 2009 KATHERINE TODRYS/HUMAN RIGHTS WATCH

It’s not a surprise to anyone who knows anything about African prisons to hear that HIV and tuberculosis (TB) rates are staggering, and that health care is virtually nonexistent. Less intuitive is the assertion that I outlined in a recent article that governments and health donors should fund criminal justice reforms as critical HIV and TB interventions.

Disease in African prisons is incubated and spread through a perfect storm of inadequate funding, lack of political will, and a desperate need for policy change. In many African countries, prison conditions are awful, and have been for years. Prisons are often miserably overcrowded. The lack of prompt isolation and treatment or screening for TB among incoming prisoners means that the disease is quickly transmitted in the packed, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies